Home/Filings/4/0001209191-19-052621
4//SEC Filing

Kabbinavar Fairooz 4

Accession 0001209191-19-052621

CIK 0001419041other

Filed

Oct 3, 8:00 PM ET

Accepted

Oct 4, 8:36 PM ET

Size

5.3 KB

Accession

0001209191-19-052621

Insider Transaction Report

Form 4
Period: 2019-10-04
Kabbinavar Fairooz
SVP Clinical Development
Transactions
  • Award

    Employee Stock Option (right to buy)

    2019-10-04+20,00020,000 total
    Exercise: $0.64Exp: 2029-10-03Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]The shares vest in a series of twelve (12) successive equal monthly installments measured from October 3, 2019.

Issuer

Tocagen Inc

CIK 0001419041

Entity typeother

Related Parties

1
  • filerCIK 0001774182

Filing Metadata

Form type
4
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 8:36 PM ET
Size
5.3 KB